Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2014
12/18/2014US20140370092 Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
12/18/2014US20140370091 Method for Producing Aqueous Enteric Coating Liquid, Solid Preparation, and Method for Producing Same
12/18/2014US20140370090 In situ, liquid-activated film coated tablets and a process for making the same
12/18/2014US20140370089 Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy
12/18/2014US20140370088 Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
12/18/2014US20140370085 Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same
12/18/2014US20140370084 Estradiol formulations and therapies
12/18/2014US20140370083 5-aminosalicylic acid capsule formulation
12/18/2014US20140370080 Histone deacetylase (hdac) inhibitors for treatment of post-surgical adhesions
12/18/2014US20140370079 Method for targeting vascular rhoj for inhibiting tumor angiogenesis
12/18/2014US20140370078 Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds
12/18/2014US20140370077 Transdermal drug delivery system containing fentanyl
12/18/2014US20140370076 Transdermal drug delivery system containing donepezil
12/18/2014US20140370060 Tear Film Stability
12/18/2014US20140370059 USE OF mTOR INHIBITORS TO ENHANCE T CELL IMMUNE RESPONSES
12/18/2014US20140370052 Inhibitors of sialoadhesin for the treatment of diseases caused by enveloped viruses
12/18/2014US20140370046 Beta-glucan compounds, compositions, and methods
12/18/2014US20140370036 COMPOSITIONS OF, AND METHODS FOR, ALPHA-1 ANTITRYPSIN FcFUSION MOLECULES
12/18/2014US20140370027 Inhibition of macrophage-synthesized wnt7b to inhibit tumor angiogenesis and metastasis
12/18/2014US20140370011 Methods of treating or preventing cognitive impairment using indane acetic acid derivatives
12/18/2014US20140370006 Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
12/18/2014US20140370005 Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
12/18/2014US20140369997 Pharmaceutical composition for a foaming eye drop
12/18/2014US20140369974 Combination therapy for a stable and long term engraftment using specific protocols for t/b cell depletion
12/18/2014US20140369963 Methods for the treatment of hepatitis b and hepatitis d infections
12/18/2014US20140369962 Methods for the treatment of hepatitis b and hepatitis d infections
12/18/2014US20140369961 Heterocyclic inhibitors of glutaminase
12/18/2014US20140369959 4'-azido, 3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
12/18/2014US20140369951 Ophthalmic compositions comprising povidone-iodine
12/18/2014US20140369943 Compositions comprising isosorbide monoesters and halogenated antimicrobial active compounds
12/18/2014US20140369938 Curcumin coated magnetite nanoparticles for biomedical applications
12/18/2014US20140369935 Liposome composite body
12/18/2014US20140366872 Aerosols for sinunasal drug delivery
12/18/2014DE202014009184U1 Gel für die Mundhöhle Gel for oral cavity
12/17/2014CN204016901U 一种烧伤护理用湿巾 One kind of burn care wipes
12/17/2014CN104220598A 骨膜素基因的表达抑制核酸分子、骨膜素基因的表达抑制方法及其用途 Periostin gene expression inhibitory nucleic acid molecule, expression of periostin gene suppression method and use thereof
12/17/2014CN104220505A 用于增塑pvc的杀真菌剂配制品 For plasticized pvc fungicide formulations
12/17/2014CN104220451A 具有hiv成熟抑制活性的c-3环烯三萜类化合物 Has-3 c cycloalkenyl triterpenoids hiv mature inhibitory activity
12/17/2014CN104220442A 新的烧化剂 New burnt agent
12/17/2014CN104220441A 烯二炔化合物、其缀合物及其用途和方法 Enediyne compound conjugates and methods for their use
12/17/2014CN104220439A 制造萘啶衍生物的方法 The method of manufacturing naphthyridine derivative
12/17/2014CN104220437A 新《2肾上腺素受体激动剂 New "2-adrenoceptor agonist
12/17/2014CN104220431A 卡巴他赛的固态形式及其制备方法 Cabazitaxel in solid form and its preparation method
12/17/2014CN104220426A 雌激素受体调节剂及其用途 Estrogen receptor modulators and their use
12/17/2014CN104220422A Ep1受体配体 Ep1 receptor ligands
12/17/2014CN104220421A 用于治疗中枢神经系统疾病的苄胺的磺酰胺衍生物 Sulfonamide derivatives for the treatment of central nervous system disorders benzylamine
12/17/2014CN104220420A 一种长效e-2肾上腺素受体激动剂的新型多晶 A long-acting e-2 adrenergic receptor agonists New Polycrystalline
12/17/2014CN104220079A 在其表面上具有组织穿刺突起的粘合结构 Adhesion structure having a tissue piercing projections on its surface
12/17/2014CN104220078A 包括硫酸软骨素和透明质酸衍生物的药物制剂 Pharmaceutical formulations include chondroitin sulfate and hyaluronic acid derivatives
12/17/2014CN104220077A 防止脱发并促进生发的试剂组合物 Prevent hair loss and promote hair growth reagent composition
12/17/2014CN104220076A 用于治疗呈现至少一种炎性组分的肠道疾病的方法 For the treatment of inflammatory bowel disease presenting at least one component of the method
12/17/2014CN104220075A (rs)-s-环丙基-s-(4-{[4-{[(1r,2r)-2-羟基-1-甲基丙基]氧基}-5-(三氟甲基)嘧淀-2-基]氣基}苯基)亚讽亚胺用于治疗特定肿瘤的用途 (Rs) -s- cyclopropyl -s- (4 - {[4 - {[(1r, 2r) -2- hydroxy-1-methylpropyl] oxy} -5- (trifluoromethyl) pyrimidin-2-yl lake] gas-yl} phenyl) Bitterness imine for the treatment of a specific tumor
12/17/2014CN104220074A 鲁拉西酮新给药方案以及其用于治疗、预防和/或控制至少一种cns病症的用途 Lurasidone new dosing regimens and the use thereof for treating, preventing and / or controlling at least one of cns disorders
12/17/2014CN104220073A Ccr3-抑制剂的用途 Ccr3- INHIBITORS
12/17/2014CN104220072A 利用氣基p比卩定治疗中风相关的感觉运动损伤的方法 P use gas-based treatment of stroke than Jie given the feeling of sports injuries related method
12/17/2014CN104220071A 抑制转接物关联激酶1以治疗疼痛 Inhibit the transfer material to treat pain associated kinase 1
12/17/2014CN104220070A 谷氨酰胺酶的杂环抑制剂 Heterocyclic glutaminase inhibitor
12/17/2014CN104220069A Trpm8拮抗剂 Trpm8 antagonist
12/17/2014CN104220068A 包含奥美沙坦酯和罗苏伐他汀或其盐的药物组合物 Pharmaceutical compositions containing olmesartan medoxomil and rosuvastatin or a salt thereof
12/17/2014CN104220067A 可用于治疗病毒性疾病的组合物 The composition can be used in the treatment of viral diseases
12/17/2014CN104220066A 紫杉醇和cdk抑制剂药物组合物 Paclitaxel and cdk inhibitor drug composition
12/17/2014CN104220065A 取代的脯氨酸/哌啶用作食欲素受体拮抗剂 Substitution of proline / piperidine used as orexin receptor antagonists
12/17/2014CN104220063A 利用细福寿草提取物或其有效物质的抗癌剂组合物 Use fine Adonis extract or effective anticancer substance composition
12/17/2014CN104220062A (3s,3s')4,4'-二硫烷二基双(3-氨基丁烷1-磺酸)和第二抗高血压药的组合 Combination (3s, 3s') 4,4'- disulfane diyl bis (3-amino-1- butane sulphonic acid) and a second anti-hypertensive drugs
12/17/2014CN104220061A 含有富马酸二甲酯的药物组合物 The pharmaceutical compositions containing dimethyl fumarate
12/17/2014CN104220060A 适用于治疗肾病变的组合物和其制备方法 For the treatment of kidney disease in the compositions and methods for their preparation
12/17/2014CN104220059A 通过给予屈昔多巴来改善姿势稳定性 By giving droxidopa to improve postural stability
12/17/2014CN104220058A 丝氨酸消旋酶抑制剂 Serine racemase inhibitors
12/17/2014CN104220057A 药物组合物和方法 Pharmaceutical compositions and methods
12/17/2014CN104220056A 4-氧代-2-戊烯酸和脑健康 4- oxo-2-pentenoic acid and brain health
12/17/2014CN104220055A 4-氧代-2-戊烯酸和皮肤色素沉着 4- oxo-2-pentenoic acid, and skin pigmentation
12/17/2014CN104220054A 4-氧代-2-戊烯酸和消化道的健康 Health 4-oxo-2-pentenoic acid and digestive tract
12/17/2014CN104220053A cAMP直接活化交换蛋白(EPAC)的调节剂 Direct activation of cAMP-exchange protein (EPAC) modulator
12/17/2014CN104220052A 用于治疗细小病毒感染的化合物 Compounds for the treatment of parvovirus infections
12/17/2014CN104220051A 自然杀伤/t细胞淋巴瘤(nktcl)易感性预狈j,诊断和治疗 NK / t-cell lymphoma (nktcl) susceptibility to pre difficult position j, diagnosis and treatment
12/17/2014CN104220049A 包含二甲双胍和dpp-4抑制剂或sglt-2抑制剂的药物组合物 Pharmaceutical compositions comprising metformin and dpp-4 inhibitor or sglt-2 inhibitors
12/17/2014CN104220041A 含有牛蒡子苷元衍生物的抗老化剂 Arctigenin derivatives containing anti-aging agent
12/17/2014CN104219959A 包含胶囊化葡萄糖酸-s-内酯的动物饲料组合物 Animal feed composition comprising the encapsulated lactone of gluconic acid -s-
12/17/2014CN104219954A 苯甲酰胺衍生物 Benzamide derivatives
12/17/2014CN104219952A 皮肤亮白组合物 Skin Brightening composition
12/17/2014CN104212672A 一种保健葡萄酒 A health wine
12/17/2014CN104212440A 一类喹唑啉类荧光探针及其制备和应用 A class of fluorescent probes Quinazoline its preparation and application
12/17/2014CN104211961A 聚天冬氨酸衍生物,其制备,纳米结构,排铅活性和应用 Polyaspartic acid derivatives, their preparation, nanostructures, and application activity Excretion
12/17/2014CN104211951A 含有金属离子的聚合物及其制备和用途 Its preparation and use of polymer containing metal ions
12/17/2014CN104211950A 一种非线性聚合物及其制备与用途 A non-linear polymer and its preparation and use
12/17/2014CN104211942A 紫杉醇-嵌段共聚物偶联物、其制备方法及用途 Taxol - block copolymer conjugates, their preparation and use
12/17/2014CN104211933A 一种包载难溶性抗肿瘤药物的聚合物微球的制备方法 One kind of poorly soluble anticancer drugs entrapped polymer microspheres prepared
12/17/2014CN104211829A 一种银耳功能性多糖的制备及应用 Preparation and application of functional polysaccharides from a fungus
12/17/2014CN104211768A e-咔啉-3-羧酸与寡肽的缀合物,其制备,纳米结构和作为抗肿瘤剂的应用 e- carboline-3-carboxylic acid with an oligopeptide conjugates, and their preparation, nanostructures and application as an antitumor agent
12/17/2014CN104211763A 阿司匹林-Arg-Gly-Asp-Val缀合物,其合成,纳米结构和作为载药体系的应用 Aspirin -Arg-Gly-Asp-Val conjugate synthesis, nanostructures and as drug application system
12/17/2014CN104211748A 6-羟基双脱氧鸟嘌呤核苷磷酸酯制备和用途 6-hydroxy-dideoxy guanosine phosphate preparation and use
12/17/2014CN104211747A 5'-磷酸-n6-(3-羟基苯基)腺苷的制备及医药用途 5'-phosphate -n6- preparation and pharmaceutical use (3-hydroxyphenyl) adenosine
12/17/2014CN104211733A 苯乙撑二氮烯六钼酸四丁基铵及其衍生物的制备方法与应用 Phenethyl support diazenecarboxylic six four preparation methods butyl ammonium molybdate and its derivatives and application
12/17/2014CN104211720A 铜咪唑-4-羧酸邻菲啰啉配合物及其在制备预防和治疗癌症药物中的应用 Imidazole-4-carboxylic acid copper phenanthroline complexes and their application in the manufacture of a medicament for the prevention and treatment of cancer
12/17/2014CN104211717A N-苯甲酰基-星孢素的多晶型形式iii和iv N- benzoyl - polymorph form staurosporine of iii and iv
12/17/2014CN104211715A 雷帕霉素的39-去甲氧基衍生物 Rapamycin 39- to methoxy derivative
12/17/2014CN104211713A 抗病毒化合物 Antiviral compounds
12/17/2014CN104211712A 含杂芳基哌啶的青蒿素衍生物、其制备方法及应用 Impurity arylpiperidine artemisinin derivatives, their preparation and use
12/17/2014CN104211711A 一种新型天然活性药物及其制备与应用 A new natural active drug and its preparation and application
12/17/2014CN104211709A 黄连碱类生物碱衍生物及其抗溃疡性结肠炎的用途 Berberine alkaloids derivatives and their use of anti-ulcer colitis
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 7860